Category: Business and Investments
Endocyte awarded patent for vitamin receptor binding drug delivery conjugates
Endocyte, Inc. has been awarded a patent from the United States Patent and Trademark Office …
Oncolytics® Biotech Inc. issues 33rd U.S. patent
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) has been granted its 33rd U.S. Patent, No. …
Biotech and the flu pandemic
Biotechnology researchers are working to create new vaccination options to help stop the next big …
Panelists ponder when the window will open
Panelists in this afternoon’s business roundtable “Window Shopping – The Buyer’s Perspective on Today’s IPO …
Healthcare reform: sustaining biotech innovation in a new world
The Eighth Annual BIO Investor Forum kicked off today with a plenary session on health …
Guest blogger post: The Lure of Translational Research
As a breast cancer advocate, I am seduced by the lure of translational research and …
The Burrill Report Interview with Jim Greenwood
The Burrill Report’s Daniel Levine spoke with Jim Greenwood, president and CEO of BIO, about …
Development continues for osteoporosis drug
Osteologix, Inc. (OLGX.OB) will continue the clinical development for its osteoporosis drug, NB S101 (strontium …
Oncolytics invests in private biotech company
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) invested in British Canadian Biosciences Corp., a privately …
Podcast with Fast Forward's Tim Coetzee
Biotech Now’s Tracy Krughoff spoke with Dr. Tim Coetzee, president of Fast Forward, a subsidiary …